from Morgan Stanley issued a price target of $147.00 for BNY on 2026-06-29 12:25:31.The adjusted price target was set to $147.00.At the time of the announcement, BNY...
Ami Fadia from Needham issued a price target of $575.00 for PRAX on 2026-06-29 12:08:23.The adjusted price target was set to $575.00.At the time of the announcement, PRAX...
from Northland Securities issued a price target of $18.50 for BNED on 2026-06-26 13:18:10.The adjusted price target was set to $18.50.At the time of the announcement, BNED...
David Smith from Truist Financial issued a price target of $160.00 for BNY on 2026-06-26 12:59:58.The adjusted price target was set to $160.00.At the time of the announcement,
from Raymond James issued a price target of $20.00 for ACHV on 2026-06-26 12:11:21.The adjusted price target was set to $20.00.At the time of the announcement, ACHV...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...